InfuSystem Holdings, Inc. ( (INFU) ) just unveiled an update.
On April 1, 2025, InfuSystem Holdings, Inc. announced the upcoming departure of CEO Richard A. DiIorio, effective May 19, 2025, with Carrie Lachance set to succeed him. Lachance, who has been with the company since 2010 and served in various leadership roles, is expected to lead the company into its next growth phase. The transition is part of a planned succession, with DiIorio remaining as an advisor during the transition. The company reaffirmed its 2025 financial guidance, projecting revenue growth of 8-10% and an adjusted EBITDA margin exceeding 18.8%, indicating continued confidence in its operational performance despite ongoing investments.
More about InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a leading national healthcare service provider that facilitates outpatient care for durable medical equipment manufacturers and healthcare providers. The company operates under a two-platform model: Patient Services, which includes Oncology, Pain Management, and Wound Therapy, and Device Solutions, which supports Patient Services with direct payer rentals, pump and consumable sales, and biomedical services. InfuSystem is headquartered in Rochester Hills, Michigan, and operates Centers of Excellence across the U.S. and Canada.
YTD Price Performance: -33.42%
Average Trading Volume: 115,165
Technical Sentiment Signal: Buy
Current Market Cap: $114.9M
Learn more about INFU stock on TipRanks’ Stock Analysis page.